According to Rajat Bose of rajatkbose.com, one can sell Arvind and UltraTech Cement.
Headwinds in the IT sector remains high but the valuations at which IT stocks are trading now looks attractive and Ashburton looks at the sector with a view of topping up its holdings, Jonathan Schiessl said.
According to Satish Gupta of Astrostocktips, textile stocks like Arvind, Century Textiles, Raymond, DCM Shriram and Bombay Dyeing will get astro support.
Axis Direct recommended hold rating on Arvind with a target price of Rs 435 in its research report dated October 26, 2016.
Ashwani Gujral of ashwanigujral.com recommends buying Maruti Suzuki, ICICI Bank, Arvind, Glenmark Pharma and Tata Communications and advises selling ONGC.
Markets are at a crucial point now and global headwinds might make the next 3-6 months challenging feels Nilesh Shah, MD & CEO of Envision Capital.
Atul Suri of Trader Rare Enterprises is of the view that one may prefer Arvind, Exide Industries and PI Industries.
Following a steady-but-not-spectacular performance in Samvat 2072 (8.5 percent up for the Sensex), shares are again likely to post similar returns in the year ahead as a revival in consumption gives earnings a fillip, according to analysts.
Prakash Gaba of prakashgaba.com is of the view that Nifty has support at 8550 and resistance at 8660 while Bank Nifty has support at 19200 and resistance at 19750.
Ashwani Gujral of ashwanigujral.com recommends selling Century Textiles and IRB Infra and advises buying UPL.
Some of the stocks that should be on your radar are: Axis Bank, Bharti Airtel, Dr Reddys Laboratories, L&T Finance Holdings, Adani Ports and Special Economic Zone, PI Industries, Crompton Greaves Consumer Electrical, Arvind, Multi Commodity Exchange of India.
VK Sharma, Head Private Broking & Wealth Management at HDFC Securities is of the view that one can buy BPCL, HPCL, TVS Motor and India Cements.
Ashwani Gujral of ashwanigujral.com recommends selling Hindustan Unilever and Jet Airways and advises buying Arvind, BPCL and TVS Motor.
The Indian economy may have improved considerably owing to a good monsoon, but Karwa says the earnings may only improve in the second half of current fiscal and will hold strong till the end of FY18.
Dipan Mehta, Member BSE & NSE, said that Axis Bank numbers were disappointing. Quarter after quarter, the NPA provisioning kept on increasing, he said.
Prakash Gaba of prakashgaba.com is of the view that Nifty has support at 8680 and resistance at 8757-8775 while Bank Nifty has support at 19821 and resistance at 19950-20000.
Gaurav Bissa of LKP Securities recommends buying Arvind and KPIT Tech and advises selling ACC.
In a BSE filing, Arvind Ltd informed about "its decision to raise about Rs 740 crore by diluting 10 percent in its brand business pegging its enterprise value at Rs 8,000 crore.
Renuka Ramnath of Multiples Equity said that the deal with Arvind is a very interesting mix of brick to luxury and the company has a unique combination of owned, licensed and specialty brands.
Speaking to CNBC-TV18, Sanjay Lalbhai, CMD of Arvind said that the company has few cash-generating businesses, which can be unlocked for value to shareholders. These can either be given to existing shareholders or crystalised or couild be put under separate boards.
Arvind, the textile manufacturer and flagship company of the Lalbhai Group, has reported a 1.5 percent growth in second quarter consolidated profit at Rs 71.7 crore on yearly basis. Revenue supported bottomline but weak margin limited growth.
Benchmark indices remained under pressure in noon trade with the Sensex falling 97.90 points to 28081.18 and the Nifty down 22.15 points at 8686.80.
Mitesh Thacker of miteshthacker.com is of the view that one can buy BHEL, Arvind, Maruti Suzuki and Jindal Steel.
Mitesh Thacker of miteshthacker.com recommends buying Kotak Mahindra Bank, Arvind, Greaves Cotton and Muthoot Finance.
Here are a few top buzzing midcap stocks picked up by CNBC-TV18's analysts in trade today. We have - Aurobindo Pharma, Arvind, Shriram EPC, PNB, ICICI Bank, Gujarat Pipavav, Zensar, Aarti Drugs, Aarti Industries, and Indian Hume.